IGFBP3 and metabolic dysfunction-associated steatohepatitis: Nevertheless, after performing a binary logistic regression, the IGF-1/intact IGFBP-3 ratio did not remain robustly associated with NASH or liver fibrosis (p = 0.06 unadjusted and p = 0.08 after adjusting for BMI and age) [29].